Cetonas

<p>Please enquire for more information about 3-(4-bromophenyl)-5-(1-methylindol-3-yl)-1H,4H,5H-1,2-diazin-6-one including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Please enquire for more information about 5-(2-methylpropyl)-3-(prop-2-ynylamino)cyclohex-2-en-1-one including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Please enquire for more information about 2,6-dichloro(3-pyridyl)4-(3-chloro-5-(trifluoromethyl)(2-pyridyl))piperazinyl ketone including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>1-(4-Amino-3,5-dichloro-phenyl)-2-ethanone is a beta-adrenergic agent. It has been used as a stable isotope label for the study of the pharmacokinetics and metabolism of drugs in humans. In addition, it has been shown to have a good stability profile in acidic solutions and can be easily converted to other derivatives by simple chemical methods. The compound's UV spectrum is linear with respect to concentration over the range from 0.1 to 1 mg/mL, with maxima at 227 nm and 254 nm. This compound has been characterized using analytical methods such as diffraction, spectroscopy, and chromatography.</p>

<p>(3,5-Dimethoxyphenyl)acetone is a plant phenolic compound that has been found in many plants. It is an intermediate in the biosynthesis of lignans and a wide range of other natural products. The production of (3,5-dimethoxyphenyl)acetone by plants is induced by the presence of nitrate, chloride and/or tyrosol. This compound also represses the expression of genes involved in dextrose metabolism and carbon fixation pathways. Furthermore, it can be quantified using isotopic labelling techniques and has been detected at low levels in human urine samples.</p>

<p>4-Fluoroandrostenedione is a synthetic, nonsteroidal compound that has been shown to be an effective androgen ablation agent. It binds to the androgen receptor, which prevents conversion of testosterone into dihydrotestosterone (DHT). 4-Fluoroandrostenedione has been used in clinical trials for the treatment of prostate cancer. This drug has also been shown to inhibit the production of estrogens by binding to the aromatase enzyme, which converts androgens into estrogens. Substitutions on the a-ring have been shown to increase its activity as an anti-cancer agent. 4-Fluoroandrostenedione can be synthesized from androstenedione by substituting a fluorine atom on one of the carbons in the a-ring.</p>